2DeBold AJ,Borenstein HB,Veress AT,et al.A rapid and poent natrindic response to intravenous injection of atrial myocandial extract in rats.Life Sci,1981,28:89～94.
3Sudoh T,Kangawa K,Minamino N,et al.A neunatriuretic peptide in porcine brain[J].Nature,1988,332:78～81.
4Nakao K,Ogawa Y,Suga S,et al.Molecular biology and biochemistry of the natriuretic peptide system I:natriuretic peptides.J Hypertens,1992,10:907～912.
5Moe,G.W.Grima,E.A.Wong,N.L,et al:Dual natriuetic peptide system in experimental heart failure,J.Am.Coll.Cardiol,1993,22:891.
6Yoshimura M,Yasue H.Okumura K,et al.Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure,Circulation,1993,87:464.
7Wei,C.M.Heublein,D.M,Perrella,M.A.et al:Natriuretic peptide system in human heart failure,Circulation,1993,88:1004.
8Salomon P,Przewlocka-Kosmala M,Orda A et al.Plasma levels of brain natriuretic peptide,cyclic 3'5'-guanosine monophosphate,endothelin-1 and noradrenaline in patients with chronic congestive heart failure.Pol Arch Med Wewn,2003 Jan,109(1):43～48.
10Calderone A.Takahashi,N,Thaik,C.M,and Colucci,W.S:Atrial natriuretic factor and cyclic guanosine monophosphate modulate cardiac myocyte growth and phenotype.Circulation:90(Suppl.l):1994.1～317.
二级参考文献10
1Maeda K,Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin - 6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol, 2000;36 (5):1581～1593
2Cargill RI, Barr CS, Coutie WJ, et al. C-type natriuretic peptide levels in corpulmonale and in congestive heart failure. Thorax, 1994;49(12): 1247～1249
3Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B - natriuretic as a rapid,point-of- care test for screening patients udnergoing echocardiography to determine left ventricular dysfunction. Am Heart J ,20011; 141 (3) :367～374
4Kawai K, Hata K,Tokaoka H, et al. Plasma brain natriuretic peptide as a nove therapeutic indicator in idiopathic dilated cardiomyopathy during beta- blocker therapy:a potential of hormone- guided treatment. Am Heart J ,2001; 141 (6) :925 ～932
5Trovate GM,Carpinteri G.Effects of atria1 fibrillation on the increase of atria1 natruretic peptide in congestive heart failure.Recenti Prog Med,1994;85:570
6Muscholl MW,Schunkert H,Muders T,et al.Neurohormone activity and left ventricular geometry in patients with essential arterial hypertension.Am Heart J,1998;135:58
6Sodoh T,Kangawa K,Minamino N,et al.A new natriuretic peptide in porcine brain.Nature,1988,332(6159):78.
7Deth R,Casteels R.A study of releasable Ca fractions in smooth muscle cells of the rabbit aorta.J Gen Physiol,1977,69(4):401.
8Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain[J]. Nature,1988,332(6159) :78-81.
9MeKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure:the Framingham study [ J ]. N Engl J Med ,1971,285 (26) :1441-1446.
10Wozakowska-Kapion B. Effect of sinus rhythm restoration on plas- ma brain natriuretic peptide in patients with atrial fibrillation [ J ]. Am J Cardio1,2004,93 ( 12 ) : 1555-1558.
